STOCK TITAN
  1. Home
  2. Sec-filings
  3. NEO
  4. [SCHEDULE 13G/A] NeoGenomics, Inc. SEC Filing

[SCHEDULE 13G/A] NeoGenomics, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock NEO logo
Neogenomics Inc

NASDAQ:NEO

NEO Rankings

#3295 Ranked by Market Cap
N/A Ranked by Dividends

NEO Latest News

Jul 1, 2025
NeoGenomics to Report Second Quarter 2025 Financial Results on July 29, 2025
Jun 30, 2025
NeoGenomics Announces PanTracer Tissue and PanTracer Tissue + HRD Now Available to Support More Informed and Timely Cancer Care
Jun 24, 2025
NeoGenomics Appoints Dr. Marjorie Green to Board of Directors
May 28, 2025
NeoGenomics Debuts PanTracer Family of Genomic Profiling Tests at ASCO 2025
May 20, 2025
NeoGenomics to Participate in Upcoming June Investor Conferences

NEO Latest SEC Filings

Jun 24, 2025
[Form 4] NeoGenomics, Inc. Insider Trading Activity
Jun 24, 2025
[Form 3] NeoGenomics, Inc. Initial Statement of Beneficial Ownership
Jun 24, 2025
[8-K] NeoGenomics, Inc. Reports Material Event

NEO Stock Data

963.92M
127.16M
1.23%
102.53%
2.71%
Diagnostics & Research
Services-testing Laboratories
Link
United States
FORT MYERS